The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH). (Q38104737)

28 August 2017

title

The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH). (English)

1 reference

28 August 2017

0 references

prostatic hypertrophy

1 reference

8

Francesco Montorsi

1 reference

28 August 2017

2

Alberto Briganti

1 reference

28 August 2017

6

Andrea Salonia

1 reference

28 August 2017

1

Giorgio Gandaglia

1 reference

28 August 2017

3

Paolo Gontero

1 reference

28 August 2017

5

Giacomo Novara

1 reference

28 August 2017

Nicola Mondaini

4

1 reference

28 August 2017

Alessandro Sciarra

series ordinal

7

1 reference

28 August 2017

language of work or name

1 reference

12 April 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

112

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

432-441

1 reference

High prevalence of benign prostatic hypertrophy in the community

28 August 2017

cites work

1 reference

Benign prostatic hyperplasia: age-related tissue-remodeling

21 January 2018

1 reference

Serum sex hormones and measures of benign prostatic hyperplasia

21 January 2018

1 reference

Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man.

21 January 2018

1 reference

Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.

21 January 2018

1 reference

The correlation between metabolic syndrome and prostatic diseases

21 January 2018

1 reference

Metabolic syndrome and benign prostatic hyperplasia: evidence of a potential relationship, hypothesized etiology, and prevention

21 January 2018

1 reference

The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation

21 January 2018

1 reference

Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review

21 January 2018

1 reference

Intraepithelial and stromal lymphocytes in the normal human prostate

21 January 2018

1 reference

Inflammation in prostate carcinogenesis

21 January 2018

1 reference

Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.

21 January 2018

1 reference

Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue

21 January 2018

1 reference

Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?

21 January 2018

1 reference

Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis.

21 January 2018

1 reference

Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia

21 January 2018

1 reference

The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial

21 January 2018

1 reference

Do prostatic infarction, prostatic inflammation and prostate morphology play a role in acute urinary retention?

21 January 2018

1 reference

The effect of intraprostatic chronic inflammation on benign prostatic hyperplasia treatment

21 January 2018

1 reference

Lower urinary tract symptoms in benign prostatic hyperplasia patients: orchestrated by chronic prostatic inflammation and prostatic calculi?.

21 January 2018

1 reference

Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial

21 January 2018

1 reference

Human C-reactive protein and the metabolic syndrome

21 January 2018

1 reference

Inflammatory process in type 2 diabetes: The role of cytokines.

21 January 2018

1 reference

Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis

21 January 2018

1 reference

The dysregulated adipose tissue: a connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis.

21 January 2018

1 reference

Prostatic calculi do not influence the level of serum prostate specific antigen in men without clinically detectable prostate cancer or prostatitis

21 January 2018

1 reference

EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines).

21 January 2018

1 reference

Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia

21 January 2018

1 reference

Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia

21 January 2018

1 reference

Malondialdehyde in benign prostate hypertrophy: a useful marker?

21 January 2018

1 reference

A Retrospective Study: Correlation of Histologic Inflammation in Biopsy Specimens of Chinese Men Undergoing Surgery for Benign Prostatic Hyperplasia With Serum Prostate-specific Antigen

21 January 2018

1 reference

Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia

21 January 2018

1 reference

Anti-CTLA-4 therapy results in higher CD4+ICOShi T cell frequency and IFN-gamma levels in both nonmalignant and malignant prostate tissues

21 January 2018

1 reference

Hexanic lipidosterolic extract of Serenoa repens inhibits the expression of two key inflammatory mediators, MCP-1/CCL2 and VCAM-1, in vitro

21 January 2018

1 reference

Biomarkers for the diagnosis of prostatic inflammation in benign prostatic hyperplasia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJU.12118

1 reference

28 August 2017

1 reference